Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 161.39M | 153.02M | 171.64M | 216.15M | 225.46M | 234.50M |
Gross Profit | 94.56M | 88.30M | 99.66M | 133.18M | 142.64M | 152.89M |
EBITDA | -20.67M | -7.89M | 12.02M | 29.65M | 54.12M | 77.37M |
Net Income | -26.96M | -41.02M | -25.01M | -21.02M | 4.14M | 16.83M |
Balance Sheet | ||||||
Total Assets | 122.59M | 78.72M | 145.18M | 196.30M | 250.49M | 214.26M |
Cash, Cash Equivalents and Short-Term Investments | 34.91M | 27.27M | 43.36M | 62.06M | 76.80M | 93.69M |
Total Debt | 26.73M | 18.47M | 39.19M | 66.89M | 76.40M | 36.97M |
Total Liabilities | 69.00M | 55.03M | 80.47M | 106.58M | 135.75M | 98.63M |
Stockholders Equity | 53.60M | 23.69M | 64.71M | 89.72M | 114.73M | 115.63M |
Cash Flow | ||||||
Free Cash Flow | 22.08M | 17.94M | 25.44M | 35.13M | 28.56M | 75.84M |
Operating Cash Flow | 24.73M | 18.78M | 28.08M | 36.44M | 36.99M | 77.08M |
Investing Cash Flow | -4.00M | -838.00K | -2.64M | -1.30M | -8.43M | -1.23M |
Financing Cash Flow | -42.91M | -34.03M | -44.14M | -49.89M | -45.44M | -45.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | HK$25.37B | 4.80 | -2.69% | 5.71% | -0.46% | -53.29% | |
56 Neutral | HK$166.00M | 92.22 | 0.60% | 4.47% | -30.83% | -89.29% | |
46 Neutral | HK$59.20M | ― | -92.80% | ― | -10.85% | -64.42% | |
46 Neutral | HK$86.26M | ― | -1969.58% | ― | -17.33% | 5.35% | |
36 Underperform | HK$307.30M | 28.12 | 31.07% | ― | 52.73% | ― |
Ulferts International Limited has announced its annual general meeting scheduled for August 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements, re-election of directors, and authorization of directors’ remuneration. The meeting will also consider resolutions to allow the company to issue additional shares and buy back issued shares, reflecting strategic moves to manage its equity and enhance shareholder value.
Ulferts International Limited, a company incorporated in Hong Kong, has announced the amendment and re-adoption of the terms of reference for its Nomination Committee. This committee, primarily composed of independent non-executive directors, is tasked with maintaining the board’s diversity and ensuring the board’s composition aligns with the company’s strategic goals. The updated terms emphasize the importance of diversity, independence, and effective governance in board nominations and evaluations.
Ulferts International Limited reported a decrease in total revenue to HK$153.0 million for the year ended 31 March 2025, amid challenging market conditions and weakening consumer sentiment. Despite efforts to adapt to market challenges, the company recorded a net loss of HK$41.0 million, impacted by an impairment loss of HK$16.1 million on property and equipment. The furniture market faced complexities due to geopolitical tensions and economic uncertainties, affecting consumer sentiment and competition. Ulferts continues to operate online platforms to maximize market coverage and revenue.
Ulferts International Limited has announced that its board of directors will convene on June 25, 2025, to approve the company’s annual results for the year ending March 31, 2025. The meeting will also consider any recommendations for a final dividend payment. This announcement is significant as it indicates the company’s ongoing financial management and potential shareholder returns.
Ulferts International Limited has issued a profit warning, indicating an expected net loss of up to HK$45 million for the fiscal year ending March 31, 2025, compared to a loss of HK$25 million the previous year. This anticipated loss is attributed to a 10% decline in total revenue and an impairment loss of approximately HK$17 million, reflecting the challenging business environment faced by the company. The final audited results are expected to be published in late June 2025, and stakeholders are advised to exercise caution when dealing with the company’s securities.